- Home
- CHRS vs EMF Comparison
CHRS vs EMF Comparison
Compare CHRS & EMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- EMF
- Stock Information
- Founded
- CHRS 2010
- EMF 1987
- Country
- CHRS United States
- EMF United States
- Employees
- CHRS 235
- EMF N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- EMF Finance/Investors Services
- Sector
- CHRS Health Care
- EMF Finance
- Exchange
- CHRS Nasdaq
- EMF Nasdaq
- Market Cap
- CHRS 134.4M
- EMF 186.2M
- IPO Year
- CHRS 2014
- EMF N/A
- Fundamental
- Price
- CHRS $1.16
- EMF $12.36
- Analyst Decision
- CHRS Strong Buy
- EMF
- Analyst Count
- CHRS 4
- EMF 0
- Target Price
- CHRS $5.38
- EMF N/A
- AVG Volume (30 Days)
- CHRS 2.4M
- EMF 29.3K
- Earning Date
- CHRS 03-12-2025
- EMF 01-01-0001
- Dividend Yield
- CHRS N/A
- EMF 6.16%
- EPS Growth
- CHRS N/A
- EMF N/A
- EPS
- CHRS N/A
- EMF N/A
- Revenue
- CHRS $304,340,000.00
- EMF N/A
- Revenue This Year
- CHRS $2.47
- EMF N/A
- Revenue Next Year
- CHRS N/A
- EMF N/A
- P/E Ratio
- CHRS N/A
- EMF N/A
- Revenue Growth
- CHRS 44.19
- EMF N/A
- 52 Week Low
- CHRS $0.66
- EMF $10.58
- 52 Week High
- CHRS $2.87
- EMF $12.67
- Technical
- Relative Strength Index (RSI)
- CHRS 38.01
- EMF 50.17
- Support Level
- CHRS $1.03
- EMF $12.02
- Resistance Level
- CHRS $1.39
- EMF $12.37
- Average True Range (ATR)
- CHRS 0.14
- EMF 0.12
- MACD
- CHRS -0.03
- EMF 0.04
- Stochastic Oscillator
- CHRS 14.04
- EMF 66.67
About CHRS Coherus BioSciences Inc.
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. The company is focused on the research, development, and commercialization of its portfolio of FDA-approved oncology products, including LOQTORZI. The company markets UDENYCA, a biosimilar of Neulasta in the United States, and expects to launch the FDA-approved Humira biosimilar YUSIMRY in the United States in 2023. The company generates revenue from the United States.
About EMF Templeton Emerging Markets Fund
Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.